Epstein-Barr virus-associated lymphoma
1 paper studies it2 more mention it
Trial sponsors
Company1 trialPhase 1/264 people
Latest
[Rinsho Ketsueki] The Japanese Journal of Clinical Hematology
iPSC-derived next-generation T cell therapy for refractory malignancies
ReviewMalignancy
Preprint
T Cell Exhaustion and Senescence in Epstein-Barr Virus-Associated Lymphoma Patients
Preprint: study in peopleMechanisms
[Rinsho Ketsueki] The Japanese Journal of Clinical Hematology
iPSC-derived rejuvenated T-cell therapy for Epstein-Barr virus-associated lymphomas
ReviewInterventions